Workflow
Sonoco(SON)
icon
Search documents
Sonnet BioTherapeutics Inc. Enters into Licensing Agreement with Alkem Laboratories Limited to Develop and Commercialize SON-080 for Diabetic Peripheral Neuropathy (DPN) in India
GlobeNewswire News Room· 2024-10-09 12:45
Sonnet to receive $1.0 million in upfront payment and up to an additional $1.0 million in milestone payments with a royalty in the low double digits on net sales, less certain expenses, in the India market Alkem to fund, develop and commercialize SON-080 for the treatment of DPN in India and commercialize SON-080 for the treatment of Chemotherapy Induced Neuropathy (CIPN) and Autonomic Neuropathy in India The estimated market size of diabetic neuropathy in India was $120.3 million in 2023 and is expected to ...
SON vs. PKG: Which Stock Is the Better Value Option?
ZACKS· 2024-09-26 16:41
Investors interested in Containers - Paper and Packaging stocks are likely familiar with Sonoco (SON) and Packaging Corp. (PKG) . But which of these two companies is the best option for those looking for undervalued stocks? Let's take a closer look. There are plenty of strategies for discovering value stocks, but we have found that pairing a strong Zacks Rank with an impressive grade in the Value category of our Style Scores system produces the best returns. The Zacks Rank is a proven strategy that targets ...
Are Investors Undervaluing Sonoco (SON) Right Now?
ZACKS· 2024-09-26 14:46
Here at Zacks, we focus on our proven ranking system, which places an emphasis on earnings estimates and estimate revisions, to find winning stocks. But we also understand that investors develop their own strategies, so we are constantly looking at the latest trends in value, growth, and momentum to find strong companies for our readers. Of these, value investing is easily one of the most popular ways to find great stocks in any market environment. Value investors use fundamental analysis and traditional va ...
Sonnet BioTherapeutics Completes Enrollment in Phase 1 Study of SON-1010 (IL12-FHAB) as a Monotherapy (SB101) for the Treatment of Solid Tumors
GlobeNewswire News Room· 2024-09-18 12:30
SON-1010 is a targeted immune activation cancer therapy designed to turn 'cold' tumors 'hot' Topline safety data of SB101 Phase 1 study expected by Q4 2024 PRINCETON, NJ, Sept. 18, 2024 (GLOBE NEWSWIRE) -- Sonnet BioTherapeutics Holdings, Inc. (the "Company" or "Sonnet") (NASDAQ: SONN), a clinical-stage company developing targeted immunotherapeutic drugs, today announced the completion of enrollment and initiation of dosing in its Phase 1 SB101 clinical trial of SON-1010 (IL12-FHAB) in adult patients with a ...
Sonoco Announces Pricing of $1.8 Billion of Senior Unsecured Notes
GlobeNewswire News Room· 2024-09-17 22:00
HARTSVILLE, S.C., Sept. 17, 2024 (GLOBE NEWSWIRE) -- Sonoco Products Company ("Sonoco" or the "Company") (NYSE: SON), a global leader in high-value sustainable packaging, today announced that it has priced an offering (the "Offering") of senior unsecured notes in a combined aggregate principal amount of $1.8 billion (collectively, the "Notes"). The Notes will be issued in three tranches: $500 million in aggregate principal amount of 4.450% notes due 2026 $600 million in aggregate principal amount of 4.600% ...
SON or ATR: Which Is the Better Value Stock Right Now?
ZACKS· 2024-09-10 16:41
Investors interested in stocks from the Containers - Paper and Packaging sector have probably already heard of Sonoco (SON) and AptarGroup (ATR) . But which of these two stocks is more attractive to value investors? We'll need to take a closer look to find out. We have found that the best way to discover great value opportunities is to pair a strong Zacks Rank with a great grade in the Value category of our Style Scores system. The Zacks Rank favors stocks with strong earnings estimate revision trends, and ...
Should Value Investors Buy Sonoco (SON) Stock?
ZACKS· 2024-09-10 14:46
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks. Of these, value investing is easily one of the most popular ways to find great stocks in any market environment. Value investors rely on traditional forms of analysis on key valuation metrics to find stocks that they believe are undervalued, leavin ...
Sonoco Initiates Review of TFP Business to Simplify Portfolio
ZACKS· 2024-09-05 16:41
Sonoco Products Company (SON) announced that it commenced a strategic review of its Thermoformed & Flexible Packaging ("TFP") business. This move is in sync with SON's ongoing strategy to streamline its portfolio and focus on fewer bigger and core businesses to generate improved returns and lower debt levels. Overview of Sonoco's TFP Business The TFP business is part of Sonoco's Consumer Packaging segment. The segment's products consist of rigid packaging (paper, metal and plastic) and flexible packaging. I ...
Sonoco Announces Review of Strategic Alternatives for the Thermoformed & Flexibles Packaging Business as Part of Further Portfolio Simplification
GlobeNewswire News Room· 2024-09-04 20:07
HARTSVILLE, S.C., Sept. 04, 2024 (GLOBE NEWSWIRE) -- Sonoco Products Company ("Sonoco" or the "Company") (NYSE: SON), a global leader in high-value sustainable packaging, today announced that it has initiated a review of strategic alternatives for the Company's Thermoformed & Flexible Packaging ("TFP") business, a part of the Company's Consumer Packaging segment. Exploring alternatives for the TFP business is expected to accelerate Sonoco's portfolio simplification strategy, improve pro forma leverage and f ...
Sonoco (SON) Beats Q2 Earnings Estimates
ZACKS· 2024-07-31 22:55
Sonoco (SON) came out with quarterly earnings of $1.28 per share, beating the Zacks Consensus Estimate of $1.26 per share. This compares to earnings of $1.38 per share a year ago. These figures are adjusted for nonrecurring items. This quarterly report represents an earnings surprise of 1.59%. A quarter ago, it was expected that this packaging maker would post earnings of $1.08 per share when it actually produced earnings of $1.12, delivering a surprise of 3.70%. Over the last four quarters, the company has ...